1. Home
  2. GOVX vs DRIO Comparison

GOVX vs DRIO Comparison

Compare GOVX & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOVX
  • DRIO
  • Stock Information
  • Founded
  • GOVX 2001
  • DRIO 2011
  • Country
  • GOVX United States
  • DRIO United States
  • Employees
  • GOVX N/A
  • DRIO N/A
  • Industry
  • GOVX Biotechnology: Pharmaceutical Preparations
  • DRIO Medical/Dental Instruments
  • Sector
  • GOVX Health Care
  • DRIO Health Care
  • Exchange
  • GOVX Nasdaq
  • DRIO Nasdaq
  • Market Cap
  • GOVX 23.8M
  • DRIO 25.1M
  • IPO Year
  • GOVX N/A
  • DRIO N/A
  • Fundamental
  • Price
  • GOVX $2.26
  • DRIO $0.69
  • Analyst Decision
  • GOVX Strong Buy
  • DRIO Strong Buy
  • Analyst Count
  • GOVX 5
  • DRIO 1
  • Target Price
  • GOVX $14.20
  • DRIO $4.00
  • AVG Volume (30 Days)
  • GOVX 715.7K
  • DRIO 121.6K
  • Earning Date
  • GOVX 11-12-2024
  • DRIO 11-07-2024
  • Dividend Yield
  • GOVX N/A
  • DRIO N/A
  • EPS Growth
  • GOVX N/A
  • DRIO N/A
  • EPS
  • GOVX N/A
  • DRIO N/A
  • Revenue
  • GOVX $3,090,161.00
  • DRIO $23,052,000.00
  • Revenue This Year
  • GOVX N/A
  • DRIO $34.58
  • Revenue Next Year
  • GOVX $150.51
  • DRIO $36.01
  • P/E Ratio
  • GOVX N/A
  • DRIO N/A
  • Revenue Growth
  • GOVX N/A
  • DRIO N/A
  • 52 Week Low
  • GOVX $1.09
  • DRIO $0.65
  • 52 Week High
  • GOVX $11.18
  • DRIO $2.60
  • Technical
  • Relative Strength Index (RSI)
  • GOVX 44.80
  • DRIO 42.80
  • Support Level
  • GOVX $2.17
  • DRIO $0.70
  • Resistance Level
  • GOVX $2.50
  • DRIO $0.80
  • Average True Range (ATR)
  • GOVX 0.17
  • DRIO 0.05
  • MACD
  • GOVX -0.04
  • DRIO 0.00
  • Stochastic Oscillator
  • GOVX 18.33
  • DRIO 32.96

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Share on Social Networks: